Psychopharmacology and Psychiatry Updates
Podcast tekijän mukaan Psychopharmacology Institute
265 Jaksot
-
Clozapine-Induced Myocarditis
Julkaistiin: 8.3.2022 -
Does Cannabis Use Cause Psychiatric Disorders?
Julkaistiin: 3.3.2022 -
Treatment Strategies for Treatment-Resistant OCD
Julkaistiin: 26.2.2022 -
Lithium Augmentation for Psychotic Depression
Julkaistiin: 21.2.2022 -
Prevention and Treatment Strategies for Agitation and Dementia
Julkaistiin: 16.2.2022 -
Choosing an Antipsychotic for Psychotic Depression
Julkaistiin: 11.2.2022 -
Neurological and Psychiatric Sequelae Due to COVID-19
Julkaistiin: 6.2.2022 -
SNRIs + Antipsychotics for Psychotic Depression
Julkaistiin: 1.2.2022 -
Approaches for Addressing Tobacco Use Disorder
Julkaistiin: 27.1.2022 -
ECT the First-Choice Treatment for Psychotic Depression
Julkaistiin: 22.1.2022 -
Metabolic Characteristics of Newer Second-Generation Antipsychotics
Julkaistiin: 17.1.2022 -
Prescribing Antipsychotics During Breastfeeding
Julkaistiin: 12.1.2022 -
Fluvoxamine for Treating COVID-19
Julkaistiin: 7.1.2022 -
Prescribing Antidepressants During Breastfeeding
Julkaistiin: 2.1.2022 -
Treatment Strategies for Acute and Chronic Insomnia
Julkaistiin: 28.12.2021 -
Drug Use in Breastfeeding and Adverse Effects
Julkaistiin: 23.12.2021 -
Marine Omega-3 Fatty Acid Supplementation for BPD
Julkaistiin: 18.12.2021 -
Breastfeeding and Estimating Infant Drug Exposure
Julkaistiin: 13.12.2021 -
A Method for Tapering Antipsychotics
Julkaistiin: 8.12.2021 -
Management of Psychiatric Comorbidities With Alcohol Use Disorder
Julkaistiin: 3.12.2021
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.